American Well Co. (NYSE:AMWL) Shares Purchased by Jane Street Group LLC

Jane Street Group LLC increased its holdings in shares of American Well Co. (NYSE:AMWL) by 21.9% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 19,260 shares of the company’s stock after acquiring an additional 3,462 shares during the period. Jane Street Group LLC owned approximately 0.13% of American Well worth $140,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the company. Compagnie Lombard Odier SCmA acquired a new stake in shares of American Well during the fourth quarter valued at $45,000. Norges Bank acquired a new stake in shares of American Well during the fourth quarter valued at $204,000. Northern Trust Corp boosted its stake in shares of American Well by 7.4% during the fourth quarter. Northern Trust Corp now owns 29,021 shares of the company’s stock valued at $210,000 after acquiring an additional 1,992 shares during the last quarter. Takeda Pharmaceutical Co. Ltd. acquired a new stake in shares of American Well during the fourth quarter valued at $564,000. Finally, Geode Capital Management LLC boosted its stake in shares of American Well by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 147,925 shares of the company’s stock valued at $1,073,000 after acquiring an additional 922 shares during the last quarter. Institutional investors and hedge funds own 56.05% of the company’s stock.

American Well Price Performance

American Well stock opened at $6.96 on Friday. The stock’s 50-day moving average is $7.10 and its 200-day moving average is $8.46. The company has a market cap of $108.57 million, a price-to-earnings ratio of -0.50 and a beta of 1.19. American Well Co. has a 12 month low of $5.00 and a 12 month high of $12.95.

American Well (NYSE:AMWL) last released its quarterly earnings data on Thursday, May 1st. The company reported ($1.73) EPS for the quarter, topping analysts’ consensus estimates of ($3.09) by $1.36. The company had revenue of $66.83 million for the quarter, compared to the consensus estimate of $60.15 million. American Well had a negative return on equity of 56.73% and a negative net margin of 81.83%. Research analysts anticipate that American Well Co. will post -9.34 EPS for the current year.

Insider Transactions at American Well

In other news, insider Phyllis Gotlib sold 4,782 shares of the stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $6.61, for a total value of $31,609.02. Following the completion of the sale, the insider now owns 141,849 shares in the company, valued at approximately $937,621.89. This trade represents a 3.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 11.82% of the company’s stock.

Analyst Ratings Changes

AMWL has been the topic of a number of analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of American Well in a research note on Friday, May 2nd. Truist Financial reduced their target price on American Well from $12.00 to $7.50 and set a “hold” rating on the stock in a research report on Thursday, April 10th. UBS Group reduced their target price on American Well from $12.00 to $9.00 and set a “neutral” rating on the stock in a research report on Thursday, May 8th. Stifel Nicolaus reduced their target price on American Well from $10.00 to $8.00 and set a “hold” rating on the stock in a research report on Friday, May 2nd. Finally, Piper Sandler reiterated a “neutral” rating and set a $8.00 target price (down from $10.00) on shares of American Well in a research report on Friday, May 23rd. Six research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $9.67.

American Well Profile

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.